In addition to the rapidly evolving TTS case definition, availability of information in healthcare databases might be limited (lack of information on D-dimer levels, anti-PF4 antibodies, platelet counts, and timing of thrombocytopenia diagnosis) to establish an algorithm that has sufficient specificity for robust assessment of the incidence of vaccine-induced TTS. The gene discussed is PF4; the disease is Thrombocytopenia.